Journal profile · Multiple
Journal of ISAKOS Joint Disorders & Orthopaedic Sports Medicine
ISSN 2059-7754 · eISSN 2059-7762 · BMJ Publishing Group
Journal of ISAKOS Joint Disorders & Orthopaedic Sports Medicine: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 3.7 (journal website); fully open access; APC about USD 2,000; median 98 days to acceptance (106 articles, last 24 months); 562 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Journal of ISAKOS Joint Disorders & Orthopaedic Sports Medicine is published by BMJ Publishing Group and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Total Knee Arthroplasty Outcomes, Knee injuries and reconstruction techniques and Shoulder Injury and Treatment, together about 45.4% of its articles. Its main subfields are Surgery. (generated from OpenAlex topic counts and CAS ranking data)
The Journal of ISAKOS (JISAKOS) is an online only orthopaedics journal that synthesizes the latest research and evidence-based guidelines in orthopaedic sports medicine and traumatology — including joint disorders — to provide busy orthopaedic surgeons and specialists a thorough reference for diagnosing and treating patients.JISAKOS is the official journal of the The International Society of Arthroscopy, Knee Surgery and Orthopaedic Sports Medicine.
From the journal's Aims & Scope
Research area (LetPub): Multiple
Editor-in-chief Olufemi R. AyeniPublisher website
Editorial board by country: 2 in mainland China (about 4%); most named United States 11, Canada 9, Italy 6, United Kingdom 4, Mainland China 2 (55 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Total Knee Arthroplasty OutcomesMedicine16.2%
- Knee injuries and reconstruction techniquesMedicine16%
- Shoulder Injury and TreatmentMedicine13.2%
- Sports injuries and preventionMedicine7.1%
- Lower Extremity Biomechanics and PathologiesEngineering5.7%
- Shoulder and Clavicle InjuriesMedicine5.3%
- Orthopedic Surgery and RehabilitationMedicine4.7%
- Orthopaedic implants and arthroplastyMedicine4.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Orthopedics | Zone 4 |
| Minor | Sport Sciences | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Orthopedics | Zone 2 |
| Minor | Sport Sciences | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 3.7Publisher website ·
- CiteScore 2026-06
- 4.6LetPub ·
- CiteScore (publisher)
- 4.6Publisher website ·
- SJR 2026-06
- 1.25LetPub ·
- SNIP 2026-06
- 1.61LetPub ·
- h-index
- 38OpenAlex ·
- i10-index
- 249OpenAlex ·
- 2-year mean citedness
- 1.67OpenAlex ·
- Self-citation rate
- 2.7%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 125LetPub ·
Articles by year OpenAlex count · 1,780 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 156 | 156 | 39 |
| 2025 | 562 | 562 | 318 |
| 2024 | 175 | 175 | 1,134 |
| 2023 | 507 | 507 | 1,214 |
| 2022 | 56 | 56 | 848 |
| 2021 | 51 | 51 | 760 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
98 daysMedian, submission to acceptance · P25–P75 63 days – 129 days
- Acceptance to online
- median 6 days (106 articles)
- Submission to online
- median 104 days
- Sample
- 106 articles with submission and acceptance dates (374 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- First decision after review
- 46 daysPublisher website ·
- Submission to acceptance
- 101 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessOpenAlex
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 2,000 / EUR 1,870 / GBP 1,600 / JPY 248,060 | — | — | |
| Publisher website | USD 2,000 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare1 items from the author guidelines
- Abstract
- ≤ 350 words
Article types accepted14, with length limits
- case reportted in the acknowledgements. Generally, case reports are 2,500 words (excluding abstract, text boxes, figure captions, tables anmain text ≤ 2,500 words · abstract ≤ 350 words · references ≤ 30
- consensus statementCONSENSUS STATEMENTLength not stated
- current concepts reviewCURRENT CONCEPTS REVIEWLength not stated
- editorialpaid to any Special Issue articles. An Editorial can range from 300-1,200 words (excluding the title and references) and should reference amain text ≤ 1,200 words
- editorial (must be invited)EDITORIAL (MUST BE INVITED)Length not stated
- letter to the editorLetters to the editor are usually fewer than 500 words and offer a viewpoint or experience about a manuscript previously published in JISAKOS. The letter should…main text ≤ 500 words · references ≤ 15
- original articleof interest (refer to Introduction). An original article is about 3,000 words long (excluding abstract, figure captions, tables and refermain text ≤ 3,000 words
- original research articleORIGINAL RESEARCH ARTICLELength not stated
- reviewld will be in three to five years. SOTA Reviews should be about 6,000 words (excluding abstract, figure captions, tables, text boxes anmain text ≤ 6,000 words
- state-of-the-art reviewSTATE-OF-THE-ART REVIEWLength not stated
- systematic reviewng to the PRISMA guidelines. Generally, systematic reviews are 4,000 words (excluding abstract, figure captions, tables and referencesmain text ≤ 4,000 words · abstract ≤ 450 words · references ≤ 100
- technical notethe orthopaedic literature. Generally, technical note articles are 1,000 words (excluding abstract, text boxes, figure captions, tables anmain text ≤ 1,000 words · abstract ≤ 200 words
- technical note: video articleTECHNICAL NOTE: VIDEO ARTICLELength not stated
- the classic (must be invited)THE CLASSIC (MUST BE INVITED)Length not stated
Policy excerpts from the journal's websiteAI use, Conflicts of interest, Publication ethics, License & copyright, Open access, Peer review, Preprints, Trial registration / reporting guidelines
- AI use Declaration of generative AI in scientific writing
The below guidance only refers to the writing process, and not to the use of AI tools to analyze and draw insights from data as part of the research process. Where authors use generative artificial intelligence (AI) and AI-assisted technologies in the writing process, authors should only use these technologies to improve readability and language. Applying the technology should be done with human o…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interest
Authors are required to sign and send a conflict of interest statement at the time of submission. Model summary
Corresponding authors, on behalf of all the authors of a submission, must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other …
Source ↗Publisher website ·- Publication ethics
See information on Ethics in publishing. Model summary
Please see our information on Ethics in publishing.
Source ↗Publisher website ·- License & copyright Copyright and License Agreement
Upon acceptance of an article, authors will be asked to complete a 'License Agreement' (see more information on this). Permitted third party reuse of open access articles is determined by the author's choice of user license.Author rightsAs an author you (or your employer or institution) have certain rights to reuse your work. More information.Responsible sharingFind out how you can share your rese…
Source ↗Publisher website ·- Open access Open access fee payment
For more information on Article Processing Charges, including discounts and waivers, see our Author APC Guide and Open Access Page. Corresponding Authors who are ISAKOS members will receive a 20% discount on the article publication charge. To learn about becoming a member, please visit: ISAKOS Membership Application. PLEASE NOTE: corresponding authors cannot be changed after the initial submission…
Source ↗Publisher website ·- Peer review Peer Review Process
This journal operates using a single-blind review process. All contributions are typically sent to a minimum of two independent expert reviewers to assess the scientific quality of the paper. The Editor is responsible for the final decision regarding acceptance or rejection of articles. The Editor's decision is final. Editors are not involved in decisions about papers which they have written thems…
Source ↗Publisher website ·- Preprints Preprints
Preprints can be shared anywhere at any time, in line with Elsevier's sharing policy. Model summary
Please note that preprints can be shared anywhere at any time, in line with Elsevier's sharing policy. Sharing your preprints e.g. on a preprint server will not count as prior publication (see 'Multiple, redundant or concurrent publication' for more information).
Source ↗Publisher website ·- Trial registration / reporting guidelines
Results posted in the same clinical trials registry in which primary registration resides are not considered prior publication if presented as a brief structured (less than 500 words) abstract or table. Model summary
JISAKOS does not consider results posted in the same clinical trials registry in which primary registration resides to be a prior publication if the results posted are presented in the form of a brief structured (less than 500 words) abstract or table.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- BMJ Publishing Group
- ISSN
- 2059-7754
- Electronic ISSN
- 2059-7762
- Society / sponsor
- The International Society of Arthroscopy
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Journal of ISAKOS Joint Disorders & Orthopaedic Sports Medicine
What CAS zone is Journal of ISAKOS Joint Disorders & Orthopaedic Sports Medicine in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of ISAKOS Joint Disorders & Orthopaedic Sports Medicine is in Zone 3 of Medicine, and in Zone 4 of the minor category Orthopedics / Sport Sciences. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of ISAKOS Joint Disorders & Orthopaedic Sports Medicine?
The journal's website gives an impact factor of 3.7; this is the journal's own figure, as LetPub lists none for it; CiteScore 4.6, h-index 38.
How long does peer review take at Journal of ISAKOS Joint Disorders & Orthopaedic Sports Medicine?
Based on the dates recorded on 106 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 98 days (interquartile range 63–129 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Journal of ISAKOS Joint Disorders & Orthopaedic Sports Medicine based?
Of the 55 board members whose country the journal's board page names, 2 (about 4%) are in mainland China; the countries named most often are United States (11), Canada (9) and Italy (6). Counted from the institutions listed on the board page; for reference only.
Which databases index Journal of ISAKOS Joint Disorders & Orthopaedic Sports Medicine?
According to LetPub and DOAJ records, Journal of ISAKOS Joint Disorders & Orthopaedic Sports Medicine is indexed in ESCI, Scopus and DOAJ. The journal's website also lists MEDLINE; that list has not been checked against each database.
Is Journal of ISAKOS Joint Disorders & Orthopaedic Sports Medicine open access, and what is the APC?
Journal of ISAKOS Joint Disorders & Orthopaedic Sports Medicine is a fully open-access journal. APC about USD 2,000.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .